What’s the cost of a human life?
December 1st 2015The expenditures for medical care in our country are “unsustainable,” says the Dallas Morning News, whereas The New York Times, in an editorial entitled “Why we must ration healthcare,” declares the monetary valuation of human life to be immoral. Everybody says we spend too much on healthcare, so they must be right. Right?
Anatomical changes with treatment in primary angle-closure spectrum eyes
December 1st 2015Quantitative techniques are important for researching changes to the anatomy of the anterior chamber angle in primary angle closure spectrum eyes. The authors evaluate the strengths and weaknesses of various such techniques: gonioscopy, ultrasound biomicroscopy, Scheimpflug imaging and anterior segment optical coherence tomography.
Researchers: No need to screen nonagenarians for diabetic retinopathy
November 17th 2015People over 90 years of age may not benefit from being screened for diabetic retinopathy, researchers say.A review of 200 randomly chosen people in the United Kingdom eligible for screening at this age found that only 2 had been referred for further evaluation of diabetic retinopathy.
Femtosecond laser-enabled approach allows treatment of high astigmatism
November 16th 2015Femtosecond laser intrastromal arcuate keratotomy (AK) under a corneal flap is feasible and appears to be safe and effective for reducing high astigmatism, according to the early experience of António Limão, MD.
Positive results reported for anti-interleukin-6 agent for uveitis
November 16th 2015Intravenous administration of the anti-interleukin-6 (IL-6) agent tocilizumab (Actemra, Genentech) is well-tolerated in patients with non-infectious uveitis involving the posterior segment and showing promising efficacy, according to interim outcomes reported by Quan Dong Nguyen, MD.
Red light technology increases tear break-up time in dry eye patients
November 15th 2015Treatment with red light technology resulted in a significant improvement in the tear break-up time in the vast majority of patients. This may be a future light treatment for the improvement of dry eye disease in patients with meibomian gland dysfunction.
Fluid-filled accommodating IOL maintains benefits after 2 years
November 15th 2015Implantation of a silicone oil-filled accommodating IOL (FluidVision, PowerVision) provides 3 to 4 D of accommodation along with excellent distance, intermediate, and near vision-all of which remain stable during follow-up to 2 years, said Louis D. Nichamin, MD.
Intraoperative aberrometry may help deliver on posthyperopic LASIK expectations
November 15th 2015Use of intraoperative aberrometry to select IOL power results in improved refractive outcomes in eyes that have a history of hyperopic LASIK, according to the results of a retrospective study reported by Dan B. Tran, MD.
Study of genetics in African Americans with glaucoma targets better care
November 15th 2015The Primary Open-Angle African American Glaucoma Genetics (POAAGG) study is an ongoing 5-year NIH-funded study designed to elucidate the genetic architecture and comorbidities associated with POAG in African Americans, said Joan M. O’Brien, MD.